Minicircle-based vaccine induces potent T-cell and antibody responses against hepatitis C virus
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Minicircle-based vaccine induces potent T-cell and antibody responses against hepatitis C virus ; volume:14 ; number:1 ; day:4 ; month:11 ; year:2024 ; pages:1-11 ; date:12.2024
Scientific reports ; 14, Heft 1 (4.11.2024), 1-11, 12.2024
- Urheber
-
Czarnota, Anna
Raszplewicz, Aleksandra
Sławińska, Aleksandra
Bieńkowska-Szewczyk, Krystyna
Grzyb, Katarzyna
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-78049-3
- URN
-
urn:nbn:de:101:1-2501222104054.710859974152
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Czarnota, Anna
- Raszplewicz, Aleksandra
- Sławińska, Aleksandra
- Bieńkowska-Szewczyk, Krystyna
- Grzyb, Katarzyna
- SpringerLink (Online service)
Ähnliche Objekte (12)
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
Rabies-based vaccine induces potent immune responses against Nipah virus
Publisher Correction: Rabies-based vaccine induces potent immune responses against Nipah virus
A combined nucleocapsid vaccine induces vigorous SARS-CD8+ T-cell immune responses
A recombinant virus-like particle vaccine against adenovirus-7 induces a potent humoral response
A survivin-responsive, conditionally replicating adenovirus induces potent cytocidal effects in adult T-cell leukemia/lymphoma
Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma
BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?
A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity
Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models
Lipo-pam™ adjuvanted herpes zoster vaccine induces potent gE-specific cellular and humoral immune responses
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
Rabies-based vaccine induces potent immune responses against Nipah virus
Publisher Correction: Rabies-based vaccine induces potent immune responses against Nipah virus
A combined nucleocapsid vaccine induces vigorous SARS-CD8+ T-cell immune responses
A recombinant virus-like particle vaccine against adenovirus-7 induces a potent humoral response
A survivin-responsive, conditionally replicating adenovirus induces potent cytocidal effects in adult T-cell leukemia/lymphoma
Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma
BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?
A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity
Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models
Lipo-pam™ adjuvanted herpes zoster vaccine induces potent gE-specific cellular and humoral immune responses
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
Rabies-based vaccine induces potent immune responses against Nipah virus
Publisher Correction: Rabies-based vaccine induces potent immune responses against Nipah virus
A combined nucleocapsid vaccine induces vigorous SARS-CD8+ T-cell immune responses
A recombinant virus-like particle vaccine against adenovirus-7 induces a potent humoral response
A survivin-responsive, conditionally replicating adenovirus induces potent cytocidal effects in adult T-cell leukemia/lymphoma
Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma
BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?
A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity
Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models